Sergio Finkielsztein

This inventor holds 44 USPTO granted patents and 12 published patent applications, plus 9 CIPO patents and 14 EPO patents, primarily in Poly-N-Acetylglucosamine. Top assignees: Marine Polymer Technologies, Inc., Novartis Ag, The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 1997-2021.

USPTO Granted Patents = 44 (Patent Applications = 12)

% Patents Active = 77.3

CIPO Patents = 9 (Patent Applications = 4)

EPO Patents = 14 (Patent Applications = 13)

Average Co-Inventor Count = 2.6

ph-index = 19

Forward Citations = 835(Granted Patents)

Location History:

Newtown, MA (US) (2007)
Chestnut Hill, MA (US) (1997 - 2013)
Newton, MA (US) (2011 - 2021)

Company Filing History:

38 out of 39

Marine Polymer Technologies, Inc.

The United States of America, as Represented by the Secretary, Department of Health and Human Services

patents

4. 2 out of 2

Marine Polymers Technologies

patents

5. 2 out of 1,424

The Brigham and Women's Hospital, Inc.

patents

where one patent can have more than one assignee

Years Active: 1997-2021

Loading Chart...

Areas of Expertise:

Poly-N-Acetylglucosamine

Hemostatic Compositions

Vascular Treatments

Cell Therapy

Nanofibers

Wound Healing

Biocompatible Compositions

Disease Treatment

Vascular Compression

Therapeutic Regimens

Pharmaceutical Compositions

Cell Proliferative Disorders

44 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11110150 - Complexes of IL-15 and IL-15Ralpha and uses thereof (2021-09-07),

2. 10765698 - Treatment of disease with poly-N-acetylglucosamine nanofibers (2020-09-08),

3. 10561677 - Anti-bacterial applications of poly-N-acetylglucosamine nanofibers (2020-02-18),

4. 10383971 - Hemostatic compositions and therapeutic regimens (2019-08-20),

5. 10335460 - IL-15 and IL-15Rα heterodimer dose escalation regimens for treating conditions (2019-07-02),

6. 10265382 - Complexes of IL-15 and IL-15Ralpha and uses thereof (2019-04-23),

7. 10252040 - Application of polymeric materials to screens to facilitate hemostasis and wound healing (2019-04-09),

8. 10206938 - Anti-bacterial applications of poly-N-acetylglucosamine nanofibers (2019-02-19),

9. 10206683 - Methods and apparatus for a manual vascular compression device (2019-02-19),

10. 9931377 - Cell expressing complexes of IL-15 and IL-15Ralpha (2018-04-03),

11. 9867625 - Methods and apparatus for a manual radial artery compression device (2018-01-16),

12. 9642871 - Anti-bacterial applications of poly-N-acetylglucosamine nanofibers (2017-05-09),

13. 9320653 - Hemostatic compositions and uses therefor (2016-04-26),

14. 9198928 - Anti-bacterial applications of poly-N-acetylglucosamine nanofibers (2015-12-01),

15. 9139664 - Hemostatic compositions and therapeutic regimens (2015-09-22),

Title: Sergio Finkielsztein - Innovator from Newton, MA

Introduction: Sergio Finkielsztein is a renowned inventor based in Newton, MA, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Sergio Finkielsztein holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, showcasing his diverse range of expertise and creativity.

Career Highlights: With a career spanning over two decades, Sergio Finkielsztein has worked with leading tech companies, research institutions, and universities to develop cutting-edge solutions that have revolutionized various industries.

Collaborations: Sergio Finkielsztein has collaborated with top scientists, engineers, and entrepreneurs from around the world, fostering a culture of innovation and excellence in all his projects.

Conclusion: Sergio Finkielsztein's passion for innovation and his relentless pursuit of technological advancement continue to inspire the next generation of inventors and entrepreneurs worldwide.